Clinical Trial Update: A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study assessed the safety, pharmacokinetics, and pharmacodynamics of once-daily inhaled AZD8630 in adults with asthma; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD8630

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 1 | Status: COMPLETED